Mar 16 • 22:13 UTC 🇲🇽 Mexico El Financiero (ES)

‘Ignoring’ everyone with the AirPods Max 2: More noise cancellation and the same price for Apple's new product

Apple has unveiled the AirPods Max 2, featuring improved noise cancellation and maintaining the same price point as its predecessor.

Apple Inc. has introduced the AirPods Max 2, an upgrade to their over-ear headphones that promises a more effective noise cancellation feature, which is now 1.5 times more effective than the original model released in late 2020. The updated design includes a USB-C connector and introduces lossless audio capabilities for wired connectivity, responding to industry trends and consumer demands for enhanced audio quality. These headphones are set to retain the same pricing as the previous model, keeping them accessible for consumers familiar with Apple's premium pricing strategy.

The AirPods Max 2 will retail for $549 and will be available for pre-order starting March 25, with an expected store arrival in early April. This new model will come in five attractive colors: blue, purple, orange, midnight, and starlight, appealing to a broader audience with varied aesthetic preferences. The continuity of the pricing strategy despite the enhanced features suggests Apple's confidence in maintaining its market position in high-end audio equipment, appealing to both existing fans of the brand and new users looking for quality sound experiences.

Apple continues to innovate within its product lines, integrating more features that had previously been exclusive to the AirPods Pro line, thus blurring the lines between its flagship products. Such enhancements reflect a trend where consumer electronics not only deliver performance boosts but also cater to personalization and aesthetics, indicating Apple's continued commitment to providing justified value for their premium customers. This move could strengthen Apple's foothold in the competitive audio market against premium rivals and may signal future developments in their product offerings.

📡 Similar Coverage